Can specialized HIV community pharmacies improve treatment?

©2012 Mary Ann Liebert Inc., publishers

Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized Walgreen pharmacies across the U.S. had significantly greater adherence to and persistence with their therapeutic drug regimens according to a study published in AIDS Patient Care and STDs.

Patricia Murphy, MPH and coauthors from Walgreen Co. and University of California San Francisco School of Pharmacy compared therapeutic anti- adherence (the degree to which patients follow their prescribed drug regimen) and persistence (the time to treatment discontinuation) for HIV/AIDS patients who used HIV-specialized pharmacies or traditional community pharmacies during the time span of a year. The study, "Impact of HIV Specialized Pharmacies on Adherence and Persistence with Antiretroviral Therapy," followed patients in nine cities across seven states. The researchers propose that their results should demonstrate the value of implementing policies to encourage the use of specialized HIV pharmacies for filling antiviral prescriptions.

"While antiretroviral treatments have dramatically increased the health and life expectancy of people infected with HIV, and helped to slow HIV transmission, these medications only work if taken on a regular basis," says Editor-in-Chief Jeffrey Laurence, MD, Director of the Laboratory for Research at Weill Medical College of Cornell University, New York, NY. "Enlisting pharmacies in a multi-pronged approach to maintaining is critical. This study demonstrates the role of the pharmacist in this important endeavor."

More information: The article is available free on the AIDS Patient Care and STDs website at http://www.liebertpub.com/apc.

add to favorites email to friend print save as pdf

Related Stories

Are there gender differences in anti-HIV drug efficacy?

Aug 09, 2012

Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration ...

Recommended for you

Preventing one case of HIV saves over $225K, study shows

Feb 27, 2015

How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new study led by a researcher at Weill Cornell Medical College and published online Feb. 24 in Medical Care, answer ...

Research captures transient details of HIV genome packaging

Feb 27, 2015

Once HIV-1 has hijacked a host cell to make copies of its own RNA genome and viral proteins, it must assemble these components into new virus particles. The orchestration of this intricate assembly process falls to a viral ...

Could an HIV drug beat strep throat, flesh-eating bacteria?

Feb 25, 2015

With antibiotic resistance on the rise, scientists are looking for innovative ways to combat bacterial infections. The pathogen that causes conditions from strep throat to flesh-eating disease is among them, but scientists ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.